{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T21:50:14Z","timestamp":1791237014904,"version":"4.1.0"},"reference-count":28,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2013,10,1]],"date-time":"2013-10-01T00:00:00Z","timestamp":1380585600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Diagnostic Microbiology and Infectious Disease"],"published-print":{"date-parts":[[2013,10]]},"DOI":"10.1016\/j.diagmicrobio.2013.06.031","type":"journal-article","created":{"date-parts":[[2013,8,13]],"date-time":"2013-08-13T01:45:14Z","timestamp":1376358314000},"page":"138-142","source":"Crossref","is-referenced-by-count":50,"title":["Mycobacterium tuberculosis rrs A1401G mutation correlates with high-level resistance to kanamycin, amikacin, and capreomycin in clinical isolates from mainland China"],"prefix":"10.1016","volume":"77","author":[{"given":"Qinglin","family":"Du","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guangming","family":"Dai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Quanxin","family":"Long","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xia","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lingling","family":"Dong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hairong","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jianping","family":"Xie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.diagmicrobio.2013.06.031_bb0005","doi-asserted-by":"crossref","first-page":"1295","DOI":"10.1128\/AAC.42.5.1295","article-title":"Mechanism of resistance to amikacin and kanamycin in Mycobacterium tuberculosis","volume":"42","author":"Alangaden","year":"1998","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.diagmicrobio.2013.06.031_bb0010","doi-asserted-by":"crossref","first-page":"2471","DOI":"10.1128\/JCM.43.5.2471-2473.2005","article-title":"Comparison of six methods of extracting Mycobacterium tuberculosis DNA from processed sputum for testing by quantitative real-time PCR","volume":"43","author":"Aldous","year":"2005","journal-title":"J Clin Microbiol"},{"key":"10.1016\/j.diagmicrobio.2013.06.031_bb0015","doi-asserted-by":"crossref","first-page":"2032","DOI":"10.1128\/AAC.01550-10","article-title":"Molecular detection of mutations associated with first- and second-line drug resistance compared with conventional drug susceptibility testing of Mycobacterium tuberculosis","volume":"55","author":"Campbell","year":"2011","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.diagmicrobio.2013.06.031_bb0020","doi-asserted-by":"crossref","first-page":"e50","DOI":"10.1086\/597010","article-title":"Multidrug-resistant tuberculosis (TB) resistant to fluoroquinolones and streptomycin but susceptible to second-line injection therapy has a better prognosis than extensively drug-resistant TB","volume":"48","author":"Chan","year":"2009","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.diagmicrobio.2013.06.031_bb0025","doi-asserted-by":"crossref","first-page":"9804","DOI":"10.1073\/pnas.1105379108","article-title":"Unusual regioversatility of acetyltransferase Eis, a cause of drug resistance in XDR-TB","volume":"108","author":"Chen","year":"2011","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.diagmicrobio.2013.06.031_bb0030","doi-asserted-by":"crossref","first-page":"1004","DOI":"10.1128\/AAC.41.5.1004","article-title":"Microplate Alamar Blue Assay versus BACTEC 460 system for high-throughput screening of compounds against Mycobacterium tuberculosis and Mycobacterium avium","volume":"41","author":"Collins","year":"1997","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.diagmicrobio.2013.06.031_bb0035","doi-asserted-by":"crossref","first-page":"1247","DOI":"10.1093\/jac\/dkr109","article-title":"Comparison of clinical isolates and in vitro selected mutants reveals that tlyA is not a sensitive genetic marker for capreomycin resistance in Mycobacterium tuberculosis","volume":"66","author":"Engstrom","year":"2011","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.diagmicrobio.2013.06.031_bb0040","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1183\/09031936.00073611","article-title":"WHO guidelines for the programmatic management of drug-resistant tuberculosis: 2011 update","volume":"38","author":"Falzon","year":"2011","journal-title":"Eur Respir J"},{"key":"10.1016\/j.diagmicrobio.2013.06.031_bb0045","doi-asserted-by":"crossref","first-page":"3353","DOI":"10.1128\/AAC.00050-09","article-title":"Sequence analyses of just four genes to detect extensively drug-resistant Mycobacterium tuberculosis strains in multidrug-resistant tuberculosis patients undergoing treatment","volume":"53","author":"Feuerriegel","year":"2009","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.diagmicrobio.2013.06.031_bb0050","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1128\/JCM.36.2.362-366.1998","article-title":"Rapid, low-technology MIC determination with clinical Mycobacterium tuberculosis isolates by using the Microplate Alamar Blue Assay","volume":"36","author":"Franzblau","year":"1998","journal-title":"J Clin Microbiol"},{"key":"10.1016\/j.diagmicrobio.2013.06.031_bb0055","doi-asserted-by":"crossref","first-page":"e33275","DOI":"10.1371\/journal.pone.0033275","article-title":"Evaluation of genetic mutations associated with Mycobacterium tuberculosis resistance to amikacin, kanamycin and capreomycin: a systematic review","volume":"7","author":"Georghiou","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.diagmicrobio.2013.06.031_bb0060","doi-asserted-by":"crossref","first-page":"800","DOI":"10.1093\/jac\/dks497","article-title":"Unexpected N-acetylation of capreomycin by mycobacterial Eis enzymes","volume":"68","author":"Houghton","year":"2013","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.diagmicrobio.2013.06.031_bb0065","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/j.molcel.2006.05.044","article-title":"Capreomycin binds across the ribosomal subunit interface using tlyA-encoded 2\u2032-O-methylations in 16S and 23S rRNAs","volume":"23","author":"Johansen","year":"2006","journal-title":"Mol Cell"},{"key":"10.1016\/j.diagmicrobio.2013.06.031_bb0070","doi-asserted-by":"crossref","first-page":"5064","DOI":"10.1128\/AAC.00851-09","article-title":"High level of cross-resistance between kanamycin, amikacin, and capreomycin among Mycobacterium tuberculosis isolates from Georgia and a close relation with mutations in the rrs gene","volume":"53","author":"Jugheli","year":"2009","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.diagmicrobio.2013.06.031_bb0075","doi-asserted-by":"crossref","first-page":"2971","DOI":"10.1128\/AAC.47.9.2971-2973.2003","article-title":"Discordant resistance to kanamycin and amikacin in drug-resistant Mycobacterium tuberculosis","volume":"47","author":"Kruuner","year":"2003","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.diagmicrobio.2013.06.031_bb0080","doi-asserted-by":"crossref","first-page":"3192","DOI":"10.1128\/AAC.49.8.3192-3197.2005","article-title":"Molecular analysis of cross-resistance to capreomycin, kanamycin, amikacin, and viomycin in Mycobacterium tuberculosis","volume":"49","author":"Maus","year":"2005","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.diagmicrobio.2013.06.031_bb0085","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1128\/AAC.49.2.571-577.2005","article-title":"Mutation of tlyA confers capreomycin resistance in Mycobacterium tuberculosis","volume":"49","author":"Maus","year":"2005","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.diagmicrobio.2013.06.031_bb0090","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1093\/jac\/dkp452","article-title":"Genetic analysis of extensively drug-resistant Mycobacterium tuberculosis strains in Lisbon, Portugal","volume":"65","author":"Perdigao","year":"2010","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.diagmicrobio.2013.06.031_bb0095","doi-asserted-by":"crossref","first-page":"1857","DOI":"10.1128\/AAC.02191-12","article-title":"Aminoglycoside cross-resistance in Mycobacterium tuberculosis due to mutations in the 5\u2032 untranslated region of whiB7","volume":"57","author":"Reeves","year":"2013","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.diagmicrobio.2013.06.031_bb0100","doi-asserted-by":"crossref","first-page":"852","DOI":"10.1126\/science.1184784","article-title":"Tuberculosis: what we don't know can, and does, hurt us","volume":"328","author":"Russell","year":"2010","journal-title":"Science"},{"key":"10.1016\/j.diagmicrobio.2013.06.031_bb0105","doi-asserted-by":"crossref","first-page":"380","DOI":"10.3201\/eid1303.061400","article-title":"Worldwide emergence of extensively drug-resistant tuberculosis","volume":"13","author":"Shah","year":"2007","journal-title":"Emerg Infect Dis"},{"key":"10.1016\/j.diagmicrobio.2013.06.031_bb0110","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1089\/mdr.2011.0063","article-title":"Mutations in the rrs A1401G gene and phenotypic resistance to Amikacin and Capreomycin in Mycobacterium tuberculosis","volume":"18","author":"Sirgel","year":"2012","journal-title":"Microb Drug Resist"},{"key":"10.1016\/j.diagmicrobio.2013.06.031_bb0115","doi-asserted-by":"crossref","first-page":"1773","DOI":"10.1128\/JCM.02501-08","article-title":"Quantitative drug susceptibility testing of Mycobacterium tuberculosis by use of MGIT 960 and EpiCenter instrumentation","volume":"47","author":"Springer","year":"2009","journal-title":"J Clin Microbiol"},{"key":"10.1016\/j.diagmicrobio.2013.06.031_bb0120","doi-asserted-by":"crossref","first-page":"1220","DOI":"10.1128\/JCM.36.5.1220-1225.1998","article-title":"Detection of kanamycin-resistant Mycobacterium tuberculosis by identifying mutations in the 16S rRNA gene","volume":"36","author":"Suzuki","year":"1998","journal-title":"J Clin Microbiol"},{"key":"10.1016\/j.diagmicrobio.2013.06.031_bb0125","doi-asserted-by":"crossref","first-page":"4795","DOI":"10.1128\/jb.179.15.4795-4801.1997","article-title":"Molecular analysis of kanamycin and viomycin resistance in Mycobacterium smegmatis by use of the conjugation system","volume":"179","author":"Taniguchi","year":"1997","journal-title":"J Bacteriol"},{"key":"10.1016\/j.diagmicrobio.2013.06.031_bb0130","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1128\/JCM.01476-09","article-title":"Polymorphisms associated with resistance and cross-resistance to aminoglycosides and capreomycin in Mycobacterium tuberculosis isolates from South Korean Patients with drug-resistant tuberculosis","volume":"48","author":"Via","year":"2010","journal-title":"J Clin Microbiol"},{"key":"10.1016\/j.diagmicrobio.2013.06.031_bb0135","series-title":"Policy guidance on drug-susceptibility testing (DST) of second-line anti-tuberculosis drugs. Report (WHO\/HTM\/TB\/2008392)","first-page":"1","author":"World Health Organization","year":"2008"},{"key":"10.1016\/j.diagmicrobio.2013.06.031_bb0140","doi-asserted-by":"crossref","first-page":"20004","DOI":"10.1073\/pnas.0907925106","article-title":"Overexpression of the chromosomally encoded aminoglycoside acetyltransferase eis confers kanamycin resistance in Mycobacterium tuberculosis","volume":"106","author":"Zaunbrecher","year":"2009","journal-title":"Proc Natl Acad Sci U S A"}],"container-title":["Diagnostic Microbiology and Infectious Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0732889313003878?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0732889313003878?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,8,1]],"date-time":"2020-08-01T21:39:05Z","timestamp":1596317945000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0732889313003878"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,10]]},"references-count":28,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2013,10]]}},"alternative-id":["S0732889313003878"],"URL":"https:\/\/doi.org\/10.1016\/j.diagmicrobio.2013.06.031","relation":{},"ISSN":["0732-8893"],"issn-type":[{"value":"0732-8893","type":"print"}],"subject":[],"published":{"date-parts":[[2013,10]]}}}